EA200801399A1 - Замещённые 5-гетероарил-1-фенилпиразольные каннабиноидные модуляторы - Google Patents
Замещённые 5-гетероарил-1-фенилпиразольные каннабиноидные модуляторыInfo
- Publication number
- EA200801399A1 EA200801399A1 EA200801399A EA200801399A EA200801399A1 EA 200801399 A1 EA200801399 A1 EA 200801399A1 EA 200801399 A EA200801399 A EA 200801399A EA 200801399 A EA200801399 A EA 200801399A EA 200801399 A1 EA200801399 A1 EA 200801399A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- phenylpyrazole
- heteroaryl
- substituted
- cannabinoid
- cannabinoid modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Настоящее изобретение направлено на замещенный 5-гетероарил-1-фенилпиразольный каннабиноидный модулятор формулы (I) или его форму и способы применения при лечении, улучшении состояния или профилактике опосредованного каннабиноидным рецептором синдрома, расстройства или заболевания.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73912905P | 2005-11-23 | 2005-11-23 | |
PCT/US2006/044890 WO2007061948A2 (en) | 2005-11-23 | 2006-11-17 | Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200801399A1 true EA200801399A1 (ru) | 2009-12-30 |
Family
ID=37983697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200801399A EA200801399A1 (ru) | 2005-11-23 | 2006-11-17 | Замещённые 5-гетероарил-1-фенилпиразольные каннабиноидные модуляторы |
Country Status (16)
Country | Link |
---|---|
US (1) | US20070117858A1 (ru) |
EP (1) | EP1966194A2 (ru) |
JP (1) | JP2009517388A (ru) |
KR (1) | KR20080070078A (ru) |
CN (1) | CN101360741A (ru) |
AU (1) | AU2006318661A1 (ru) |
BR (1) | BRPI0618856A2 (ru) |
CA (1) | CA2630699A1 (ru) |
CR (1) | CR10111A (ru) |
EA (1) | EA200801399A1 (ru) |
EC (1) | ECSP088468A (ru) |
IL (1) | IL191585A0 (ru) |
MX (1) | MX2008006739A (ru) |
NO (1) | NO20082505L (ru) |
WO (1) | WO2007061948A2 (ru) |
ZA (1) | ZA200805405B (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8853205B2 (en) | 2005-01-10 | 2014-10-07 | University Of Connecticut | Heteropyrrole analogs acting on cannabinoid receptors |
WO2010104488A1 (en) * | 2009-02-19 | 2010-09-16 | University Of Connecticut | Novel hetero pyrrole analogs acting on cannapinoid receptors |
GB0625196D0 (en) * | 2006-12-18 | 2007-01-24 | 7Tm Pharma As | Modulators of cannabinoid receptor |
US7943653B2 (en) * | 2007-08-13 | 2011-05-17 | Janssen Pharmaceutica N.V. | Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
US10053444B2 (en) | 2009-02-19 | 2018-08-21 | University Of Connecticut | Cannabinergic nitrate esters and related analogs |
AR087701A1 (es) * | 2011-08-31 | 2014-04-09 | Japan Tobacco Inc | Derivados de pirazol con actividad inhibidora de sglt1 |
BR112019013493A2 (pt) * | 2017-01-10 | 2020-01-07 | National Health Research Institutes | Compostos heterocíclicos e seus usos |
CA3125847A1 (en) | 2020-07-27 | 2022-01-27 | Makscientific, Llc | Process for making biologically active compounds and intermediates thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2948718A (en) * | 1960-08-09 | New n-heterocyclic compounds | ||
US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
GR68380B (ru) * | 1979-06-01 | 1981-12-28 | Wellcome Found | |
LU83729A1 (fr) * | 1981-11-04 | 1983-09-01 | Galephar | Sels d'acide valproique,leur preparation et leur utilisation |
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
US5242940A (en) * | 1987-05-29 | 1993-09-07 | Ortho Pharmaceutical Corporation | Pharmacologically active N-1 and C-5 heterocyclic pyrazoles and method for synthesizing the same |
US5242942A (en) * | 1992-04-28 | 1993-09-07 | Mcneilab, Inc. | Anticonvulsant fructopyranose cyclic sulfites and sulfates |
US5384327A (en) * | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
ITMI20041032A1 (it) * | 2004-05-24 | 2004-08-24 | Neuroscienze S C A R L | Compositi farmaceutici |
US20060025448A1 (en) * | 2004-07-22 | 2006-02-02 | Cadila Healthcare Limited | Hair growth stimulators |
-
2006
- 2006-11-16 US US11/560,431 patent/US20070117858A1/en not_active Abandoned
- 2006-11-17 EA EA200801399A patent/EA200801399A1/ru unknown
- 2006-11-17 CA CA002630699A patent/CA2630699A1/en not_active Abandoned
- 2006-11-17 MX MX2008006739A patent/MX2008006739A/es unknown
- 2006-11-17 JP JP2008542393A patent/JP2009517388A/ja not_active Withdrawn
- 2006-11-17 EP EP06838057A patent/EP1966194A2/en not_active Withdrawn
- 2006-11-17 AU AU2006318661A patent/AU2006318661A1/en not_active Abandoned
- 2006-11-17 CN CNA2006800514935A patent/CN101360741A/zh active Pending
- 2006-11-17 WO PCT/US2006/044890 patent/WO2007061948A2/en active Application Filing
- 2006-11-17 KR KR1020087015034A patent/KR20080070078A/ko not_active Application Discontinuation
- 2006-11-17 BR BRPI0618856-7A patent/BRPI0618856A2/pt not_active Application Discontinuation
-
2008
- 2008-05-20 IL IL191585A patent/IL191585A0/en unknown
- 2008-05-23 EC EC2008008468A patent/ECSP088468A/es unknown
- 2008-06-05 NO NO20082505A patent/NO20082505L/no not_active Application Discontinuation
- 2008-06-20 ZA ZA200805405A patent/ZA200805405B/xx unknown
- 2008-06-23 CR CR10111A patent/CR10111A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2630699A1 (en) | 2007-05-31 |
BRPI0618856A2 (pt) | 2011-09-13 |
ZA200805405B (en) | 2009-11-25 |
KR20080070078A (ko) | 2008-07-29 |
MX2008006739A (es) | 2009-03-04 |
EP1966194A2 (en) | 2008-09-10 |
WO2007061948A2 (en) | 2007-05-31 |
US20070117858A1 (en) | 2007-05-24 |
AU2006318661A1 (en) | 2007-05-31 |
JP2009517388A (ja) | 2009-04-30 |
WO2007061948A3 (en) | 2007-07-12 |
IL191585A0 (en) | 2008-12-29 |
CN101360741A (zh) | 2009-02-04 |
CR10111A (es) | 2009-01-14 |
NO20082505L (no) | 2008-08-12 |
ECSP088468A (es) | 2008-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200601760A1 (ru) | Тетрагидроиндазольные модуляторы каннабиноидов | |
EA200800889A1 (ru) | Гексагидроциклооктилпиразольные каннабиноидные модуляторы | |
EA200801399A1 (ru) | Замещённые 5-гетероарил-1-фенилпиразольные каннабиноидные модуляторы | |
EA200800888A1 (ru) | Модуляторы каннабиноидов на основе замещенных 3-амидотетрагидроиндазолилов | |
EA200970737A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
EA200700702A1 (ru) | Аналоги локсапина и способы их применения | |
EA201170288A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
CY1111579T1 (el) | Νεα συνδυασμενη χρηση μιας ενωσης σουλφοναμιδης (sulfonamide) στην θεραπεια του καρκινου | |
ATE550037T1 (de) | Zusammensetzungen gegen das sars-coronavirus und ihre verwendungen | |
RS52780B (en) | MEANS OF PREVENTION AND TREATMENT OF DISORDERS CONCERNING MODULATION OF RYR RECEPTORS | |
EA200601912A1 (ru) | Применение пептидных соединений для профилактики и лечения хронической головной боли | |
DE602006013191D1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
EA200601267A1 (ru) | Модуляторы рецепторов андрогена | |
MX2010001714A (es) | Moduladores de canabinoides 5-vinilfenil-1-fenil-pirazol sustituidos. | |
EA200800890A1 (ru) | Модуляторы гексагидроциклогептапиразол каннабиноида | |
UA98487C2 (en) | Hexahydro-cycloheptapyrazole cannabinoid modulators | |
EA200701584A1 (ru) | Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения | |
EA200401032A1 (ru) | Антиинфарктные молекулы | |
ATE479691T1 (de) | 4,5,6,7-tetrahydrothienoä2,3-cüpyridine als h3- modulatoren | |
CR9479A (es) | Moduladores canabinoides de tetrahidrotiopirano pirazol | |
EA200600534A1 (ru) | Сочетание ингибитора обратного захвата серотонина и амоксапина |